(Q39494655)

12 September 2017

title

PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells (English)

1 reference

12 September 2017

1 reference

1 reference

2

1 reference

12 September 2017

3

En-Tang Kang

1 reference

12 September 2017

4

Woo Seok Choe

1 reference

12 September 2017

Lihan Tan

1

1 reference

12 September 2017

Xiaodi Su

series ordinal

5

1 reference

12 September 2017

publication date

4 August 2011

1 reference

Macromolecular Bioscience

12 September 2017

published in

1 reference

12 September 2017

volume

11

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1331-1335

1 reference

Targeting cancer cells with nucleic acid aptamers.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Targeting of monoclonal antibodies to tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

PEGylation, successful approach to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Modification of thiol functionalized aptamers by conjugation of synthetic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Doxorubicin in experimental and clinical heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Mfold web server for nucleic acid folding and hybridization prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

Targeted delivery of multifunctional magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201100173

21 January 2018

Identifiers

DOI

10.1002/MABI.201100173

1 reference

12 September 2017

1 reference